Unspecified MannKind trial medication

· Mannkind Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified MannKind trial medication, covering 2012-04-30 to 2012-04-30. Get the full timeline:

Most recent: Clinical Trial Update: 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes [Phase 2]

See pricing